Radoslava is a PhD candidate focusing on homologous recombination dysfunction as a predictive biomarker in solid tumors at the Oncology Institute of St. Elizabeth in Bratislava. This researcher has advanced training in immunology and molecular biology, including an MSc with distinction from the University of Aberdeen in Scotland. Radoslava’s academic work spans immunotherapy, host–pathogen interactions, supported by hands-on experience with microfluidic systems and molecular interaction studies. She is a co-author of peer-reviewed publications in Nucleic Acids Research and Computational and Structural Biotechnology Journal and a recipient of the University of Aberdeen Immunology and Immunotherapy Excellence Prize